ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
HT1_3_contig_4_177 # 178383 # 178571 # 1 # ID=4_177;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.376	HT1_3_contig_4_177 	178383	178571	+	Strict	500	20.7866	OXA-225	100.0	3001493	protein homolog model	n/a	n/a	penam; cephalosporin	antibiotic inactivation	OXA beta-lactamase	ATGACTGTGAGTTTTAAACGTTTTTTTCAGCTCTTTCTTTTTTATTTTCTCTCGATTCTGGTGGCCTATGGCCTGATTGCGTTTCTAGCAGTAGATAATTTTTGGCTGGTCGTCTGTTTGATGACAATTGTCGGCTACCTCACCTTGGGTATCCCACTAACCTTATTGAGTTTAAAGAAGAAAAAATAA	MTVSFKRFFQLFLFYFLSILVAYGLIAFLAVDNFWLVVCLMTIVGYLTLGIPLTLLSLKKKK	MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKSQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII	22.71	gnl|BL_ORD_ID|57|hsp_num:0	326
HT1_3_contig_5_154 # 168329 # 168694 # -1 # ID=5_154;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.478	HT1_3_contig_5_154 	168329	168694	-	Strict	1100	22.3274	oleB	100.0	3003036	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGGATATCAACGGTGCATCTATTAGAGGAAGGGCTTTGAAAGTATGTTTGGTCTTATTGTTCGCTTTCGGGTTTACAAGAACGAGTTTTGGCGAGGAGAGACGTTCAACGGAAACGGAGGGGACAGTGGGGTTTACCGGGATTTATGAGCCTTTGGATCAACCAGAACCATCTCCACCAACCGGTCCTGTTCCGCGTCCACCGCAAGACACGGGTAAACCCGGCGGGCAGCTGCCCCAGACAAACTTCATTCAACGGTTGGATTGGGTGATTCTTGGAAGTCTCTTGCTGATCACCGCACTTAACATATACGTAGTAAAACAACTTATCAAAAAAGGGAAATCAACATTCCCTAAGTGGGGCTAG	MDINGASIRGRALKVCLVLLFAFGFTRTSFGEERRSTETEGTVGFTGIYEPLDQPEPSPPTGPVPRPPQDTGKPGGQLPQTNFIQRLDWVILGSLLLITALNIYVVKQLIKKGKSTFPKWG	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	21.27	gnl|BL_ORD_ID|1480|hsp_num:0	1388
HT1_3_contig_9_100 # 97153 # 97725 # 1 # ID=9_100;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.449	HT1_3_contig_9_100	97153	97725	+	Strict	300	317.775	vanXYC	80.21	3002966	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanXY; glycopeptide resistance gene cluster	ATGAATCCCTATCTACAGTTAGTTAGCAAAGAATTTCCGTTAGAAAAAAACCAAGAGCCGCCTCATTTAGTCCTTGCTGCCTTCAGTGAAGACGAGGTTTACTTGCAACCAGAAGCAGCCAAACAATGGAAACGGCTAGTCAAAGCTTTAAAGCTTGAAGACGAGATCTGCTTATTAGATGGCTACCGAACCGAAAAGCAGCAACGGTATTTATGGGAATATTCCTTGAAAGAAAATGGGCTAGCCTATACGAAACAATTTGTGGCATTGCCCGGGTGCAGTGAACATCAGTTAGGCTTAGCGATCGATGTTGGTTTAAAAGGCAGCCAGGATGATTTGATCTGCCCACGATTTCGTGACAGCGCAGCGGCGGATTTATTTACCCAGGAAATGATGAACTATGGGTTTATTTTACGCTATCCCGCGGACAAACAGGAAATTACAGGGATTGGCTATGAACCATGGCATTTTCGTTATGTCGGTCTGCCCCATAGTCAAATCATCGCCAGCCAACAGTGGACCTTGGAAGAATACCATCAATACCTTGAACAAACGGCGAGGCAGTTCGCATGA	MNPYLQLVSKEFPLEKNQEPPHLVLAAFSEDEVYLQPEAAKQWKRLVKALKLEDEICLLDGYRTEKQQRYLWEYSLKENGLAYTKQFVALPGCSEHQLGLAIDVGLKGSQDDLICPRFRDSAAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIIASQQWTLEEYHQYLEQTARQFA	MNTLQLINKNHPLKKNQEPPHLVLAPFSDHDVYLQPEVAKQWERLVRATGLEKDIRLVDGYRTEKEQRRLWEYSLKENGLAYTKQFVALPGCSEHQIGLAIDVGLKKQEDDDLICPHFRDSAAADLFMQQMMNYGFILRYPEDKQEITGISYEPWHFRYVGLPHSQVITAQKWTLEEYHDYLAQTVRQFA	100.00	gnl|BL_ORD_ID|1858|hsp_num:0	97
HT1_3_contig_9_102 # 99923 # 100618 # 1 # ID=9_102;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.411	HT1_3_contig_9_102	99923	100618	+	Strict	400	434.106	vanRC	89.18	3002922	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGCAGAAAAAATAATTGTTGTTGATGATGAAAAAGAAATCGCCGAGTTAGTCACGACGTTTCTAAGGAATGAAGGCTTTCAAGTGGAACCTTTTTATGATGGAACGAGTGCTTTGGCTTATCTCGAAAAAGAAACAGTCGATGTGGCAGTTTTAGATGTGATGCTGCCGGATATCGACGGCTTTCAGCTGTTACAGACCATTCGCAAAACCCACTTTTTTCCAGTACTGATGCTCACTGCCAAAGGAGAAGATCTGGATAAAATTACCGGTCTAAGTCTAGGTGCAGATGATTATGTGACGAAACCCTTCAATCCATTAGAAGTTGTTGCTCGGGTCAAAACGCAACTACGGCGATACCAACGATACAATCAGTCAGCTGTTCCGCAGAAGATTGAAGAATACGAAAAGGAAGGCTTACTGTTGAAAATCAACAGTCACCAATGTTATCTTTATGGCAAAGAGGTTTTCTTGACCCCCATCGAATTTAAAATCCTGCTTTACTTATTTGAACACCAAGGATCGGTCGTTGCCTCAGAAACTCTTTTTGAAGCAGTCTGGAAAGAAAAATATTTAGACAACAATAACACAGTGATGGCACATATTGCCCGTCTGCGGGAAAAGCTAAACGAACAACCCCGCAAACCGAAATTAATCAAAACTGTATGGGGGGTCGGCTATATCATTGAAAAATAG	MAEKIIVVDDEKEIAELVTTFLRNEGFQVEPFYDGTSALAYLEKETVDVAVLDVMLPDIDGFQLLQTIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRYQRYNQSAVPQKIEEYEKEGLLLKINSHQCYLYGKEVFLTPIEFKILLYLFEHQGSVVASETLFEAVWKEKYLDNNNTVMAHIARLREKLNEQPRKPKLIKTVWGVGYIIEK	MSEKIVVVDDEKEIADLVTTFLQNEGFSVQPFYDGTSAIAYIEKEAIDLAVLDVMLPDIDGFQLLQQIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRYQRYNHSTASPTVEEYEKDGLILKINSHQCILYGKEVFLTPIEFKILLYLFEHQGSVVSSETLFEAVWKEKYLDNNNTVMAHIARLREKLHEEPRKPKLIKTVWGVGYIIEK	100.00	gnl|BL_ORD_ID|911|hsp_num:0	1547
